MTOR, mechanistic target of rapamycin kinase, 2475
N. diseases: 68; N. variants: 36
Source: CURATED ×
Variant | Gene | Disease | Risk Allele | Score vda | Association Type | Original DB | Sentence supporting the association | PMID | PMID Year | ||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
|
|
T | 0.800 | GeneticVariation | GWASDB | Association of variants in FRAP1 and PDGFRA with corneal curvature in Asian populations from Singapore. | 21665993 | 2011 | ||||||
|
|
|
T | 0.800 | GeneticVariation | GWASCAT | Association of variants in FRAP1 and PDGFRA with corneal curvature in Asian populations from Singapore. | 21665993 | 2011 | ||||||
|
|
|
G | 0.800 | CausalMutation | CLINVAR | |||||||||
|
|
|
0.800 | GeneticVariation | UNIPROT | ||||||||||
|
|
|
0.800 | GeneticVariation | UNIPROT | ||||||||||
|
|
|
C | 0.800 | CausalMutation | CLINVAR | |||||||||
|
|
|
G | 0.800 | CausalMutation | CLINVAR | |||||||||
|
|
|
0.800 | GeneticVariation | UNIPROT | ||||||||||
|
|
|
0.800 | GeneticVariation | UNIPROT | ||||||||||
|
|
|
G | 0.800 | CausalMutation | CLINVAR | |||||||||
|
|
|
0.800 | GeneticVariation | UNIPROT | ||||||||||
|
|
|
T | 0.800 | CausalMutation | CLINVAR | |||||||||
|
|
|
G | 0.800 | CausalMutation | CLINVAR | |||||||||
|
|
|
0.800 | GeneticVariation | UNIPROT | ||||||||||
|
|
|
A | 0.800 | CausalMutation | CLINVAR | |||||||||
|
|
|
T | 0.800 | CausalMutation | CLINVAR | |||||||||
|
|
|
A | 0.800 | CausalMutation | CLINVAR | |||||||||
|
|
|
C | 0.800 | CausalMutation | CLINVAR | |||||||||
|
|
|
0.800 | GeneticVariation | UNIPROT | ||||||||||
|
|
|
T | 0.800 | CausalMutation | CLINVAR | |||||||||
|
|
|
T | 0.800 | CausalMutation | CLINVAR | |||||||||
|
|
|
A | 0.700 | GeneticVariation | GWASCAT | Meta-analysis of genome-wide association studies for body fat distribution in 694 649 individuals of European ancestry. | 30239722 | 2019 | ||||||
|
|
|
0.700 | GeneticVariation | GWASCAT | Leveraging Polygenic Functional Enrichment to Improve GWAS Power. | 30595370 | 2019 | |||||||
|
|
|
0.700 | GeneticVariation | GWASCAT | Leveraging Polygenic Functional Enrichment to Improve GWAS Power. | 30595370 | 2019 | |||||||
|
|
|
G | 0.700 | GeneticVariation | GWASCAT | Genome-wide association analyses identify new loci influencing intraocular pressure. | 29617998 | 2018 |